Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunhild von Amsberg

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Deutsche Medizinische Wochenschrift (1946)|January 29, 2024
[Advanced renal cell carcinoma - an overview of current systemic therapy]Moritz Kaune, Carsten Bokemeyer, Gunhild von Amsberg
Aktuelle Urologie|March 28, 2022
[Update on systemic treatment of urothelial cancer: therapy in transition]Robert Tauber, Gunhild von Amsberg, Maria De Santis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2026
Targeted Radiation, Unintended EvolutionKatharina Lueckerath, Boris Hadaschik, Ken Herrmann, et al.
Aktuelle Urologie|January 22, 2026
[Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications]Gunhild von Amsberg, Arndt Hartmann, Markus Eckstein, et al.
Expert Opinion on Pharmacotherapy|December 3, 2015
Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developmentsChristoph Oing, Christoph Seidel, Gunhild von Amsberg, et al.
Aktuelle Urologie|June 27, 2019
[50 years of systemic therapy of urinary bladder cancer]Margitta Retz, Gunhild von Amsberg, Thomas Horn, et al.
World Journal of Urology|July 25, 2016
Platinum-refractory germ cell tumors: an update on current treatment options and developmentsChristoph Oing, Winfried H Alsdorf, Gunhild von Amsberg, et al.
Aktuelle Urologie|October 27, 2025
[Therapy Management of PARP Inhibitor Combinations in mCRPC Clinical Practice]Margitta Retz, Angelika Borkowetz, Katja Wittenzellner, et al.
Der Urologe. Ausg. A|January 28, 2022
[Metastatic urothelial carcinoma-guideline-based therapy and new options]Günter Niegisch, Gunhild von Amsberg, Marc Rehlinghaus, et al.
Oncology Research and Treatment|February 7, 2018
Treatment of Metastatic Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE) - Long-Term Disease Control by Multimodal TherapyJulia Quidde, Winfried H Alsdorf, Gunhild von Amsberg, et al.
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Deutsche Medizinische Wochenschrift (1946)|January 29, 2024
[Advanced renal cell carcinoma - an overview of current systemic therapy]Moritz Kaune, Carsten Bokemeyer, Gunhild von Amsberg
Aktuelle Urologie|March 28, 2022
[Update on systemic treatment of urothelial cancer: therapy in transition]Robert Tauber, Gunhild von Amsberg, Maria De Santis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2026
Targeted Radiation, Unintended EvolutionKatharina Lueckerath, Boris Hadaschik, Ken Herrmann, et al.
Aktuelle Urologie|January 22, 2026
[Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications]Gunhild von Amsberg, Arndt Hartmann, Markus Eckstein, et al.
Expert Opinion on Pharmacotherapy|December 3, 2015
Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developmentsChristoph Oing, Christoph Seidel, Gunhild von Amsberg, et al.
Aktuelle Urologie|June 27, 2019
[50 years of systemic therapy of urinary bladder cancer]Margitta Retz, Gunhild von Amsberg, Thomas Horn, et al.
World Journal of Urology|July 25, 2016
Platinum-refractory germ cell tumors: an update on current treatment options and developmentsChristoph Oing, Winfried H Alsdorf, Gunhild von Amsberg, et al.
Aktuelle Urologie|October 27, 2025
[Therapy Management of PARP Inhibitor Combinations in mCRPC Clinical Practice]Margitta Retz, Angelika Borkowetz, Katja Wittenzellner, et al.
Der Urologe. Ausg. A|January 28, 2022
[Metastatic urothelial carcinoma-guideline-based therapy and new options]Günter Niegisch, Gunhild von Amsberg, Marc Rehlinghaus, et al.
Oncology Research and Treatment|February 7, 2018
Treatment of Metastatic Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE) - Long-Term Disease Control by Multimodal TherapyJulia Quidde, Winfried H Alsdorf, Gunhild von Amsberg, et al.
Pageof 13